US Stock MarketDetailed Quotes
TRIB Trinity Biotech
- 1.6900
- -0.0400-2.31%
Close May 7 16:00 ET
16.00MMarket Cap-5399P/E (TTM)
1.8100High1.6500Low19.95KVolume1.7200Open1.7300Pre Close33.79KTurnover0.47%Turnover RatioLossP/E (Static)9.47MShares5.500052wk High-0.67P/B7.26MFloat Cap1.650052wk Low--Dividend TTM4.29MShs Float143.4487Historical High--Div YieldTTM9.25%Amplitude1.6500Historical Low1.6930Avg Price1Lot Size
Trinity Biotech Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,154.83%-11.56M | -86.78%242K | -789.94%-4.66M | -128.67%-4.42M | -82.05%-2.72M | -106.96%-921K | -57.71%1.83M | -60.16%676K | -272.81%-1.93M | -124.54%-1.49M |
| Net income from continuing operations | 41.43%-24.02M | 45.42%-5.5M | 24.86%-6.72M | 38.31%-5.99M | 52.69%-5.81M | -4,786.74%-41.01M | -696.76%-10.08M | -777.14%-8.95M | -1,139.59%-9.71M | -402.22%-12.28M |
| Operating gains losses | -16,764.86%-12.48M | 532.58%385K | -75.46%40K | -6,609.95%-12.82M | -311.90%-89K | 70.63%-74K | 68.88%-89K | 61.39%163K | 30.80%-191K | --42K |
| Depreciation and amortization | -23.83%1.78M | -30.84%462K | -69.22%229K | 85.44%484K | -8.79%602K | -14.98%2.33M | 78.61%668K | -4.12%744K | -68.05%261K | --660K |
| Deferred tax | 69.27%-59K | 80.00%-3K | 7,300.00%222K | -820.69%-267K | 92.67%-11K | -14.97%-192K | 98.73%-15K | -98.80%3K | -104.43%-29K | ---150K |
| Other non cash items | -58.97%10.14M | 153.73%1.1M | -55.28%2.75M | -60.24%3.7M | -77.09%2.59M | 4,336.45%24.71M | -188.93%-2.05M | 2,023.13%6.15M | 482.83%9.3M | --11.31M |
| Change In working capital | -107.02%-402K | -49.41%4.58M | -1,620.92%-2.33M | 41.63%-1.29M | -8.00%-1.36M | 3,430.81%5.73M | 209.01%9.06M | 108.61%153K | 29.73%-2.22M | -169.02%-1.26M |
| -Change in receivables | 208.39%1.05M | ---- | ---- | ---- | ---- | -115.49%-966K | ---- | ---- | ---- | ---- |
| -Change in inventory | -10.72%-971K | ---- | ---- | ---- | ---- | 80.10%-877K | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -1,629.83%-2.77M | ---- | ---- | ---- | ---- | 102.38%181K | ---- | ---- | ---- | ---- |
| -Change in other working capital | -69.00%2.29M | ---- | ---- | ---- | ---- | 32.24%7.39M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,154.83%-11.56M | -86.78%242K | -789.94%-4.66M | -128.67%-4.42M | -82.05%-2.72M | -106.96%-921K | -57.71%1.83M | -60.16%676K | -272.81%-1.93M | -124.54%-1.49M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 514.19%24.76M | 21.64%-891K | 33.08%-886K | 1,647.03%27.86M | 22.51%-1.33M | 31.23%-5.98M | 54.06%-1.14M | 32.41%-1.32M | 15.49%-1.8M | 40.80%-1.72M |
| Net PPE purchase and sale | 27.07%-803K | 47.37%-250K | 60.12%-128K | -5.59%-151K | -69.14%-274K | 39.24%-1.1M | 16.67%-475K | -17.58%-321K | 63.24%-143K | 76.89%-162K |
| Net intangibles purchase and sale | 61.01%-1.9M | 3.17%-641K | 50.95%-492K | 75.09%-413K | 77.14%-355K | 29.12%-4.88M | 65.25%-662K | 40.51%-1M | 4.82%-1.66M | ---1.55M |
| Net business purchase and sale | --28.16M | --0 | ---266K | --28.43M | ---- | --0 | --0 | --0 | --0 | ---- |
| Net investment purchase and sale | ---700K | --0 | --0 | --0 | ---700K | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 514.19%24.76M | 21.64%-891K | 33.08%-886K | 1,647.03%27.86M | 22.51%-1.33M | 31.23%-5.98M | 54.06%-1.14M | 32.41%-1.32M | 15.49%-1.8M | 40.80%-1.72M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -30.19%-16.04M | -25.66%-1.76M | -2.49%-2.43M | -410.93%-13.45M | 112.49%1.61M | -104.72%-12.32M | 60.89%-1.4M | -226.72%-2.37M | 257.86%4.33M | -829.71%-12.87M |
| Net issuance payments of debt | 69.30%-7.37M | 7.35%-555K | 16.52%-571K | 30.13%-10.64M | 156.83%4.25M | -1,942.47%-24M | 19.16%-599K | 5.79%-684K | -1,949.66%-15.23M | -524.32%-7.49M |
| Net common stock issuance | --0 | --0 | --0 | --0 | ---- | --25.34M | --317K | --0 | --25.02M | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | 81.68%-1.05M | --0 | ---- | 74.07%-905K | ---- | -577.24%-5.74M | --63K | ---- | ---3.49M | ---2.32M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -30.19%-16.04M | -25.66%-1.76M | -2.49%-2.43M | -410.93%-13.45M | 112.49%1.61M | -104.72%-12.32M | 60.89%-1.4M | -226.72%-2.37M | 257.86%4.33M | -829.71%-12.87M |
| Net cash flow | ||||||||||
| Beginning cash position | -74.61%6.58M | -13.69%6.26M | 36.11%14.23M | -58.52%4.15M | -74.61%6.58M | -5.19%25.91M | -73.60%7.25M | -63.47%10.45M | -68.98%10.01M | -5.19%25.91M |
| Current changes in cash | 85.21%-2.84M | -240.20%-2.41M | -164.27%-7.98M | 1,581.82%9.99M | 84.83%-2.44M | -1,205.71%-19.22M | 59.06%-709K | -205.67%-3.02M | 115.82%594K | -424.85%-16.08M |
| Effect of exchange rate changes | 60.71%-44K | -578.79%-158K | 107.82%14K | 155.56%85K | -92.31%14K | -303.64%-112K | -80.24%33K | -16.23%-179K | -261.05%-153K | --182K |
| End cash Position | -43.89%3.69M | -43.89%3.69M | -13.69%6.26M | 36.11%14.23M | -58.52%4.15M | -74.61%6.58M | -74.61%6.58M | -73.60%7.25M | -63.47%10.45M | -68.98%10.01M |
| Free cash flow | -106.74%-14.26M | -193.52%-649K | -715.43%-5.28M | -33.46%-4.98M | -4.33%-3.35M | -251.70%-6.9M | -62.59%694K | -147.33%-648K | -268.51%-3.73M | -200.69%-3.21M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg